January 8, 2019
Kaken Pharmaceutical and Corbus Pharmaceuticals Holdings entered into a strategic collaboration agreement on January 3 for the development and commercialization of the US company’s investigational systemic sclerosis and dermatomyositis treatment lenabasum in Japan. Lenabasum is a small molecule drug that...read more